Tiotropium suppresses acetylcholine-induced release of chemotactic mediators in vitro
- 1 November 2007
- journal article
- Published by Elsevier BV in Respiratory Medicine
- Vol. 101 (11), 2386-2394
- https://doi.org/10.1016/j.rmed.2007.06.009
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Muscarinic receptor signaling in the pathophysiology of asthma and COPDRespiratory Research, 2006
- Pathophysiology of airflow limitation in chronic obstructive pulmonary diseaseThe Lancet, 2004
- Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPDEuropean Respiratory Journal, 2004
- Muscarinic acetylcholine receptors and airway diseasesPharmacology & Therapeutics, 2003
- Tiotropium in the management of chronic obstructive pulmonary disease.European Respiratory Journal, 2002
- Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium.European Respiratory Journal, 2002
- A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary diseaseEuropean Respiratory Journal, 2002
- The Impact of Aging and Smoking on the Future Burden of Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Antimuscarinic treatment for lung diseases: From research to clinical practiceLife Sciences, 2001
- Acetylcholine and substance P stimulate bronchial epithelial cells to release eosinophil chemotactic activityJournal of Applied Physiology, 1998